FDA 510 (k) Imréitithe nGLÉAS LASER CAILLTEANAS DON hair I MNÁ AGUS FIR: éifeachtúlachta nó Just SÁBHÁILTEACHTA?
|

|
- Tá 510 FDA (k) aighneacht an phríomh-mheicníocht a úsáidtear a thabhairt isteach le feistí leighis isteach sa mhargadh.
- Aighneacht a léiriú go bhfuil "equivalency substaintiúil". A cheangal ar aighneachtaí go leor sonraí a éifeachtúlacht ó staidéir dhea-rialú cliniciúil
- HairMax san aighneacht torthaí an staidéir éifeachtúlachta mór cliniciúla a chruthaíonn
- Is próiseas dian Aighneacht a dtiocfaidh imréiteach a éilíonn go gcloífear le déantúsaíochta go docht agus a rialú cáilíochta.
- HairMax ach Imréitithe FDA léasair i leith caillteanais gruaige mhargú lena n-úsáid sa bhaile.
|
|
|
| |
|
Is é an (k) 510 aighneacht an phríomh-mheicníocht trína feistí leighis a ghlacfar ar an margadh i Stáit Aontaithe Mheiriceá. An FDA sonraí a éilíonn go n-éileamh ar ais coibhéis, sonraí tuairisciúil agus sonraí feidhmíochta chun tacú leis an gcineál seo aighneacht.
Tá misperception ginearálta go nglanann an FDA feistí leighis léasair agus le haghaidh margaíochta amháin bunaithe ar chruthúnas ar an tsábháilteacht. Ní hé sin an bonn tuisceana ceart i ngach cás, mar tá freisin anailís a rinneadh chun athbhreithniú a dhéanamh ar sonraí cliniciúla chun bunús na n-éileamh míochaine le haghaidh gléas nua.
The purpose of a 510k submission to the FDA is to demonstrate that a device is “substantially equivalent” to a predicate device (one that has been FDA cleared or marketed before 1976). The submission compares and contrasts the subject and predicate devices, explaining why any differences between them should be acceptable. While human data is not required for all 510(k), in many cases efficacy data from well-controlled clinical studies are required especially for new indications. According to an official with the FDA, "Many of 510(k) submissions contain or require clinical data to demonstrate substantial equivalence”.
|
| |
|
This is especially true for a new indication such as “promotion of hair growth” with lasers.
The HairMax LaserComb was subject to this more stringent requirement and the submission of a large clinical study complying with all Good Clinical Practices in support of the efficacy of the device, led to the clearance to market the HairMax LaserComb by the FDA in 2007. |

|
|
| |
|
There have been allegations that the 510(k) process for clearing new medical devices might be ‘cursory’. In a letter to the N.Y. Times newspaper in November 2008, the Director of the Center for Devices and Radiological Health, FDA responded to this allegation as follows:
“……….under the congressionally established 510(k) process, the FDA often reviews laboratory and clinical data to substantiate the medical claims for a new device, based on the product’s nature and potential risk.
The data are then reviewed by experts within, and sometimes outside, the FDA. The 510(k) process is an important tool for ensuring that devices entering the market do not raise new questions regarding safety or effectiveness”
In conclusion, the 510(k) submission process is a rigorous one that leads to clearance to market a device, but also requires adherence to strict manufacturing and quality controls.
|
| |
| The HairMax LaserComb is the only Laser Phototherapy Device to be given clearance to market by the FDA for the regrowth of hair in males and females with certain classes of androgenetic alopecia. * |
| |
| |
| Tá Shástacht Chustaiméirí a bhfuil Tábhacht Bunscoile |
Cliniciúil cruthaithe chun cinn * Fás Gruaige |
Níos mó ná 90% Sástacht Úsáideoir Tuairiscithe |
Paitinnithe agus monaraithe i Stáit Aontaithe Mheiriceá |
Dearbhaithe Cáilíochta ISO |
Baill bródúil as an Bhiúró Gnó Níos Fearr |
|
|
| |
*The HairMax Advanced 7, Lux 9, and the Professional 12 models are indicated to treat Androgenetic Alopecia, and promote hair growth in fireannaigh who have Norwood Hamilton Classifications of IIa to V and in baineannaigh who have Ludwig (Savin) I-4, II-1, II-2, or patrúin tosaigh an chaillteanais gruaige agus a bhfuil an dá bhfuil Cineálacha Craiceann Fitzpatrick I go IV.
|
|